Distribution and Spread of Susceptible and Resistant Gonorrhea in New York City
Isolates were clustered based on patient sexual behavior and race/ethnicity to assess antibiotic resistance as a major driver of gonorrhea transmission in NYC.
Gonorrhea
Caution Required When Using Supplementary Nucleic Acid Amplification Tests for Gonorrhea
Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.
Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin
For patients with gonorrhea, detection of the wild-type serine 91 genotype of the gyrA gene of Neisseria gonorrhoeae is predictive of a successful treatment outcome with ciprofloxacin.
Gonorrhea Test ResistancePlus GC Granted Breakthrough Device Status
The FDA has granted Breakthrough Device designation to ResistancePlus GC,, a test that detects ciprofloxacin susceptibility.
Bexsero Vaccine Has Potential for Cross-Protection Against Gonorrhea
Meningococcal vaccine antigens may generate an immune response that recognizes gonococcal proteins.
Zoliflodacin: Promising New Treatment for Urogenital Gonorrhea
Zoliflodacin was effective in treating gonococcal urogenital and rectal infections, but less effective in the treatment of pharyngeal gonorrhea.
Gepotidacin Shows Potential in Treating Resistant Neisseria Gonorrhoeae
Gepotidacin, a novel triazaacenaphthelene bacterial type II topoisomerase inhibitor shows potential in treating resistant Neisseria gonorrhoeae.
CDC: Increase in Rate of STDs for Fourth Consecutive Year in the United States
Nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the United States in 2017.
Point-of-Care Molecular Test Effectively Detects Chlamydia, Gonorrhea
A new point-of-care molecular test for CT and NG has the same accuracy as conventional nucleic acid amplification tests in certain settings.
CDC Report on Recommendation Adherence in Uncomplicated Gonorrhea Treatment
Improving provider adherence to treatment recommendations for antibiotic use across the full spectrum of healthcare settings is an integral part of a comprehensive approach to combating the emergence of antimicrobial-resistant gonorrhea.
-
Loading...
-
Loading...
Next post in Sexually Transmitted Diseases
